| Literature DB >> 24957587 |
Roxana Elena Lazarescu1, Kelley Bohm1.
Abstract
Bowel perforation is a potentially fatal complication of obstruction, ischaemia, trauma, surgery and medications. It is recognised by clinical suspicion based on history, symptoms of severe abdominal pain and signs such as rebound tenderness, as well as imaging showing free air in the abdomen. Bevacizumab (aka avastin) is an antineoplastic recombinant monoclonal antibody that inhibits angiogenesis in a variety of malignancies. Colonic perforation is a recognised but rare complication of this therapy, likely due to aforementioned bowel ischaemia or compromised mucosal microcirculation which increases susceptibility to injury. We are presenting a case of an unrecognised bowel perforation caused in a patient with abdominal carcinomatosis. 2014 BMJ Publishing Group Ltd.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24957587 PMCID: PMC4069698 DOI: 10.1136/bcr-2014-204643
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X